Applicant, as named in the Orange Book

Blueprint Medicines

Next listed expiry: Ayvakit on 10 Apr 2040. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ayvakit · 5 strengths avapritinib	avapritinib	212608	10 Apr 2040	patent, carve-out possible

Recent events

24 Oct 2026Ayvakit · Exclusivity expires within 90 days ODE-3669 Jan 2027
24 Oct 2026Ayvakit · Exclusivity expires within 90 days ODE-3669 Jan 2027
24 Oct 2026Ayvakit · Exclusivity expires within 90 days ODE-3669 Jan 2027
24 Oct 2026Ayvakit · Exclusivity expires within 90 days ODE-3669 Jan 2027
24 Oct 2026Ayvakit · Exclusivity expires within 90 days ODE-3669 Jan 2027